9th S.M.A.R.T. Lecture held by Professor Wolfgang Lutz
Population trends and the global sustainable development goals The 9th S.M.A.R.T. Lecture held by Professor Wolfgang Lutz, Founding Director of the Wittgenstein Centre for Demography and Global Human Capital (IIASA, VID/ÖAW, WU), was a plea for education. Particularly female education not only connects to a decrease of child mortality and to an increase of life expectancy, it proves to be key to the alleviation of poverty. In his talk, Wolfgang…
CeMM position on genome editing in the light of recent reports about gene-edited babies
Following internal discussions at CeMM on human genome editing – prompted by recent reports on the birth of gene-edited babies using CRISPR technology in China – we distance ourselves from human trials performed without adequate ethical approval by the responsible institutions and in violation of both local regulations and the international consensus in the scientific community. CeMM welcomes responsible research on understanding and advancing…
Kaan Boztug receives ERC Consolidator Grant
Kaan Boztug, Director of the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases (LBI-RUD), is awarded a prestigious Consolidator Grant of the European Research Council (ERC) for research on human immune dysregulation. Kaan Boztug, Director of the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases (LBI-RUD), Adjunct PI at CeMM and Professor of Pediatrics at the Medical University of Vienna and St. Anna Children’s Hospital,…
International PhD Program in Molecular Technologies and Systems Medicine CALL OPEN
Do you want to work in an environment that promotes free-minded scientific creativity, and translate your findings to impact medical practice and improve healthcare?Are you excited to gain a new understanding of the molecular physiology and pathology of humans?Do you want to join an international group of highly collaborative and successful colleagues that help you achieve your training and research goals?Are you a person who enjoys teamwork…
New mechanism controlling the master cancer regulator uncovered
Who regulates the key regulator? The Superti-Furga laboratory at CeMM reports online in the journal Science about a newly discovered mechanism by which RAS proteins, central to cancer signaling, are regulated in their activity and localization. Of the more than 23,000 genes in the human genome, only a handful assume a very central role in signal transduction and growth regulation. Of these, the three genes encoding RAS proteins are particularly…
Welcome to new CeMM and LBI-RUD Adjunct PIs
We are happy to announce that during Summer/Autumn we had a successful search for new CeMM and LBI-RUD Adjunct Principal Investigators. A warm WELCOME to: Miriam Unterlass (CeMM) - Materials Chemistry, Technical University of ViennaNuno Maulide (CeMM) – Organic Chemistry, University of ViennaAndreas Villunger (CeMM/LBI-RUD) – Division of Developmental Immunology, Medical University of InnsbruckThomas Reiberger (LBI-RUD/CeMM) – Division of…
Basophils - underestimated players in lung development
The adult lung consists of different, highly specialized cell types that are protected by a variety of immune cells. Using advanced single cell sequencing methods, researchers of the Weizmann Institute of Science in Israel, the CeMM and the Medical University in Vienna discovered a hitherto unknown, fundamental role of basophils in the development of macrophages in the lung. The study, published in Cell, could open new clinical strategies to…
New Artwork by Klaus Pamminger at CeMM
We are happy and proud to announce a new piece of art located in the small seminar room at CeMM: Stiegenhaus, 11 Square Albin Cachot, 75013 Paris-13E / RC01-BDJ 2018Balsa wood, lacquer, multi-partapprox. 270 x 520 x 32 cm The artwork is a generous gift from our befriended artist Klaus Pamminger who has already contributed a piece of art to the CeMM Brain Lounge. Until Summer 2018 the wall sculpture was part of the exhibition COLLAGE at the…
CeMM Outing 2018
To start the academic year with a community experience CeMM had its yearly Outing on Friday, October 5, 2018. This year´s thematic focus was on traffic and public transport, and built on our previous SMART lecture held by architect and urban design consultant Jan Gehl on “Livable cities for the 21st century”. We were very glad for the opportunity to visit the light rail manufacturing plant of Siemens Mobility GmbH in the 11th district of Vienna…
Epigenetic analysis of aggressive brain tumors
Glioblastoma is a brain cancer with devastating prognosis. A new collaborative study by scientists from CeMM, MedUni Vienna and the Austrian Brain Tumor Registry network demonstrates how epigenetic analysis of tumor samples collected in routine clinical practice could be used to better classify and treat the disease. The results were published in Nature Medicine. Glioblastoma is an aggressive brain cancer with a high degree of molecular…
Adjunct Principal Investigator Positions at LBI-RUD and CeMM, Vienna (NEW APPLICATION DEADLINE!)
Thank you for the interest and applications! We will contact the candidates asap. CeMM and LBI-RUD plan to invite several candidates to a hearing, which will take place in the last week of September 2018. Adjunct Principal Investigator Positions at LBI-RUD and CeMM, ViennaStarting or consolidated level to begin in 2018/2019 CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences and LBI-RUD, the Ludwig Boltzmann…
Faulty cytoskeleton impairs immune cells
The rearrangement of the cell´s inner scaffold, the cytoskeleton, is a vital process for immune cells. In a new collaborative study, led by scientists from LBI-RUD/CeMM, a rare inherited disease revealed a hitherto unknown role of a cytoskeleton-regulating factor for the proper functioning of the adaptive immune system. The study was published in the Journal of Allergy and Clinical Immunology. In order to move, a body needs a strong scaffold.…
Rare disease reveals crucial factor for fat digestion
Patients with congenital diarrheal disorders, a group of rare inherited diseases with largely unknown mechanisms, suffer from severe to life-threatening diarrhea and nutrient malabsorption from birth. Using state-of-the-art genetic and molecular biology analysis methods involving the revolutionary gut organoid technology, researchers from the LBI-RUD and CeMM, together with the Medical University of Innsbruck and University Medical Center Utrecht…
RESOLUTE: 13 academic and industry partners join forces to unlock the solute carrier class of transporters for effective new therapies
RESOLUTE (Research empowerment on solute carriers), a public-private research partnership supported by the Innovative Medicines Initiative (IMI) with 13 partners from academia and industry, announced the start of a 5-year research project on July 1, 2018. The goal of the project is to intensify worldwide research on solute carriers (SLCs), a relatively understudied group of proteins that control essential physiological functions, and potentially…
EU-LIFE urges the European Parliament and the EU Council to push for a strong Horizon Europe
EU-LIFE, the alliance of 13 leading life science research institutes in Europe announced its reaction to the European Commission´s proposal for Horizon Europe, the next Framework Programme for Research and Innovation (FP9) that will run from 2021 to 2027. The key points are as follows: • EU-LIFE urges the European Parliament and the EU Council to push for a stronger Horizon Europe by raising its budget as recommended by several…
